Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Zinc for Wilson’s Disease: What is Known and Unknown
11
Mins
June 2024
Zinc salts are one of three approved treatments for the autosomal recessive condition Wilson’s disease (WD). Their use was first described…
Read more
8
Mins
31st May 2016
Nonsurgical Treatment for Localised Hepatocellular Carcinoma
The majority of patients (worldwide) diagnosed with hepatocellular carcinoma (HCC) in 2016 will not be candidates for a potentially curative therapy…
9
Mins
31st May 2016
Fatty Liver Disease: A Crosstalk Between Lipid Species
he role of different lipid species such as free fatty acids and sphingolipids in non-alcoholic fatty liver disease (NAFLD) has been extensively studied…
9
Mins
31st May 2016
Immunopathogenesis of Hepatitis B Virus Infection and Related Complications
Chronic hepatitis B (CHB) is a serious consequence of hepatitis B virus (HBV), which infects and replicates in the liver.
9
Mins
31st May 2016
Manifestation of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Different Dietary Mouse Models
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are usually associated with obesity and metabolic syndrome, are…
9
Mins
31st May 2016
Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Diagnosis and Treatment
Portal vein thrombosis (PVT) is considered a common complication of liver cirrhosis. Its prevalence increases with liver disease severity, reaching 25%…
5th April 2016
Treatment Opportunities for Colorectal Liver Metastases
Colorectal liver metastases (CLM) are the most common hepatic malignancy and are caused by disseminated tumour cells (DTCs) seeded early in the…
5th April 2016
Alcoholic Liver Disease: A Comprehensive Review
Alcoholic liver disease, a leading cause of morbidity, mortality, and cirrhosis, can range from simple steatosis to hepatocellular carcinoma.
5th April 2016
Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
An alarming rise of obesity and, along with it, non-alcoholic fatty liver disease (NAFLD), has been observed in the USA and the rest of the world.
Loading posts...
« Previous
1
…
10
11
12
13
14
…
17
Next »